iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEK)

Category Sector Equity Biotechnology

This ETF can be held in an Investment ISA, SIPP and Investment Account

Sell

£5.0825

Buy

£5.095

arrow-down£-0.0082 (-0.16%)

Prices updated at 06 Jan 2025, 16:34 GMT

Prices minimum 15 mins delay

Prices in GBP

Investment objective

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

FTSE All-Share

0.28%

LSE

Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual performance (%)

Year	This fund	Sector Equity Biotechnology
31 Dec 14 - 31 Dec 15	-	-
31 Dec 15 - 31 Dec 16	-	-
31 Dec 16 - 31 Dec 17	-	-
31 Dec 17 - 31 Dec 18	-5.80	-7.96
31 Dec 18 - 31 Dec 19	21.63	20.20
31 Dec 19 - 31 Dec 20	23.11	25.97
31 Dec 20 - 31 Dec 21	0.90	-9.03
31 Dec 21 - 31 Dec 22	-1.56	-7.84
31 Dec 22 - 31 Dec 23	0.33	-1.28
31 Dec 23 - 31 Dec 24	-0.32	-3.25

Morningstar category: Sector Equity Biotechnology

Trailing returns (%)

Year	This fund	Sector Equity Biotechnology
1 Day	-0.34	0.85
1 Month	-3.75	-4.43
3 Months	-1.87	-0.77
6 Months	0.84	3.32
1 Year	0.64	0.79
3 Years annualised	0.27	-0.77
5 Years annualised	4.70	4.63

Morningstar category: Sector Equity Biotechnology

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.